IHMT-EZH-2-115

N/A

Report date: 2022/06/29 15:08:26
NME

Base Information

Drug NameIHMT-EZH-2-115
Drug Alias NameIHMT-EZH-2-115
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitors
TargetsHistone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesHefei Academy Of Physical Sciences, Chinese Academy Of Sciences
Inactive CompaniesN/A
Active IndicationsLymphoma, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A